Shanghai Chemspec Corporation(SH:688602)2025-01-22 09:20Financial Performance Forecast - The company expects a net loss attributable to shareholders of the parent company for 2024 to be between -46 million and -55 million CNY, a decrease of 140.82% to 148.80% compared to the previous year [3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -85 million and -100 million CNY, representing a decrease of 205.91% to 224.60% year-on-year [3]. - The total profit for the previous year was 125.81 million CNY, with a net profit attributable to shareholders of 112.70 million CNY [6]. Market Conditions and Business Segments - The decline in performance is primarily due to weak market conditions influenced by macroeconomic factors, leading to pressure on product prices while costs remain rigid [7]. - In the new materials segment, demand for high-priced products is declining despite increased sales efforts, while the average price of products in the new energy battery materials market has decreased [7]. - The CDMO segment's business decline is mainly affected by significant variations in customer order cycles due to changes in downstream pharmaceutical sales and production plans [7]. Operational Status and Risks - The company maintains normal business operations with sufficient cash flow and has not encountered significant adverse changes in production and operations [7]. - The performance forecast has not been audited by a registered accountant and is based on preliminary calculations by the finance department [8]. - Investors are advised to pay attention to investment risks as the forecast data is preliminary and subject to change upon the release of the audited annual report [9].